nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.02.2022 | Original Article

Omentin-1 and its relationship with inflammatory factors in maternal plasma and visceral adipose tissue of women with gestational diabetes mellitus

verfasst von: M. I. Peña-Cano, J. Valencia-Ortega, E. Morales-Ávila, M. F. Díaz-Velázquez, R. Gómez-Díaz, R. Saucedo

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the association of omentin-1 and inflammatory factors in serum and visceral adipose tissue (VAT) of women with gestational diabetes mellitus (GDM) compared to normal pregnant (NP) subjects. Furthermore, to examine their correlation with maternal clinical characteristics.

Methods

We compared 116 GDM women to 115 NP women, at the time of cesarean section. Circulating omentin-1 and pro-inflammatory (IL-1β, IL-6, TNF-α), and anti-inflammatory cytokines (IL-1RA, IL-10) were examined. Moreover, their mRNA expression in VAT, along with inflammatory factors involved in the NF-κB pathway (TLR2, TLR4, NF-κB, IKκB), were examined.

Results

Circulating omentin-1 (p = 0.022) was lower and circulating IL-1-β, IL-1RA, as well as IL-10 (p = 0.005, p = 0.007, and p = 0.015, respectively), were higher in GDM compared to NP women. Omentin-1 correlated negatively with pre-pregnancy and gestational BMI, and HOMA-IR in all women, but was not associated with cytokines. TLR2, TLR4, IL-1β, IL-1RA, IL-6, IL-10 mRNA expression in VAT was lower in GDM compared with controls (p < 0.05 all). In multivariate analysis, BMI at delivery was significantly correlated to omentin-1 concentrations in all and NP subjects. In addition, omentin-1 expression was correlated to inflammatory gene expression in all, GDM and NP, women (p < 0.05 all).

Conclusion

Serum levels and VAT gene expression of omentin-1 are not independently linked to GDM; notwithstanding, GDM women have a VAT-altered inflammatory status. In addition, no systemic association between omentin-1 and inflammatory factors was found, whereas associations between their expression in all women were observed, indicating that expression of these adipokines is linked between them regardless of GDM.

McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P (2019) Gestational diabetes mellitus. Nat Rev Dis Primers 5:47. https://doi.org/10.1038/s41572-019-0098-8CrossRefPubMed

Fasshauer M, Blüher M, Stumvoll M (2014) Adipokines in gestational diabetes. Lancet Diabetes Endocrinol 2:488–499. https://doi.org/10.1016/S2213-8587(13)70176-1CrossRefPubMed

Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong DW (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290:E1253-1261. https://doi.org/10.1152/ajpendo.00572.2004CrossRefPubMed

Watanabe T, Watanabe KK, Takahashi Y, Kojima M, Watanabe R (2017) Adipose tissue-derived omentin-1 function and regulation. Compr Physiol 7:765–781. https://doi.org/10.1002/cphy.c160043CrossRefPubMed

de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, McLenithan JC (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56:1655–1661. https://doi.org/10.2337/db06-1506CrossRefPubMed

Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y (2011) Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 408:339–343. https://doi.org/10.1016/j.bbrc.2011.04.039CrossRefPubMed

Kazama K, Usui T, Okada M, Hara Y, Yamawaki H (2012) Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol 686:116–123. https://doi.org/10.1016/j.ejphar.2012.04.033CrossRefPubMed

Barker G, Lim R, Georgiou HM, Lappas M (2012) Omentin-1 is decreased in maternal plasma, placenta and adipose tissue of women with pre-existing obesity. PLoS One 7:e42943. https://doi.org/10.1371/journal.pone.0042943CrossRefPubMedPubMedCentral

Tsiotra PC, Halvatsiotis P, Patsouras K, Maratou E, Salamalekis G, Raptis SA, Dimitriadis G, Boutati E (2018) Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus. Peptides 101:157–166. https://doi.org/10.1016/j.peptides.2018.01.005CrossRefPubMed

10.

Pan BL, Ma RM (2016) Correlation of serum omentin-1 and chemerin with gestational diabetes mellitus. Nan Fang Yi Ke Da Xue Xue Bao 36:1231–1236PubMed

11.

Souvannavong-Vilivong X, Sitticharoon Ch, Klinjampa R, Keadkraichaiwat I, Sripong Ch, Chatree S, Sririwichitchai R, Lertbunnaphong T (2019) Placental expressions and serum levels of adiponectin, visfatin, and omentin in GDM. Acta Diabetol 56:1121–1131. https://doi.org/10.1007/s00592-019-01355-0CrossRefPubMed

12.

Mierzynski R, Dłuski D, Nowakowski L, Poniedziałek-Czajkowska E, Leszczyńska-Gorzelak B (2018) Adiponectin and omentin levels as predictive biomarkers of preterm birth in patients with gestational diabetes mellitus. Biomed Res Int 2018:7154216. https://doi.org/10.1155/2018/7154216CrossRefPubMedPubMedCentral

13.

Abell SK, Shorakae S, Harrison CL, Hiam D, Moreno A, Stepto NK, De Courten B, Teede HJ (2017) The association between dysregulated adipocytokines in early pregnancy and development of gestational diabetes. Diabetes Metab Res Rev 33:e2926. https://doi.org/10.1002/dmrr.2926CrossRef

14.

Lewandowski K, Nadel I, Lewinski A, Bienkiewicz M, Tan B, Randeva HS, Cypryk K (2010) Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices. Ginekol Pol 81:907–912PubMed

15.

Franz M, Polterauer M, Springer S, Kuessel L, Haslinger P, Worda C, Worda K (2018) Maternal and neonatal omentin-1 levels in gestational diabetes. Arch Gynecol Obstet 297:885–889. https://doi.org/10.1007/s00404-018-4652-5CrossRefPubMedPubMedCentral

16.

Lappas M (2014) Activation of inflammasomes in adipose tissue of women with gestational diabetes. Mol Cell Endocrinol 382:74–83. https://doi.org/10.1016/j.mce.2013.09.011CrossRefPubMed

17.

Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM (1996) IRS-1- mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:665–668. https://doi.org/10.1126/science.271.5249.665CrossRefPubMed

18.

Ballak DB, Stienstra R, Tack CJ, Dinarello CA, van Diepen JA (2015) IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance. Cytokine 75:280–290. https://doi.org/10.1016/j.cyto.2015.05.005CrossRefPubMedPubMedCentral

19.

Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston PL, Friedman JE, Kalhan SC, Catalano PM (2002) TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207–2213. https://doi.org/10.2337/diabetes.51.7.2207CrossRefPubMed

20.

Atègbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K, Miled A, Grissa A, Jerbi M, Tabka Z, Khan NA (2006) Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 91:4137–4143. https://doi.org/10.1210/jc.2006-0980CrossRefPubMed

21.

Saucedo R, Valencia J, Moreno-González LE, Peña-Cano MI, Aranda-Martínez A, García Y, Díaz-Velázquez MF, Hernández-Valencia M (2021) Maternal serum adipokines and inflammatory markers at late gestation and newborn weight in mothers with and without gestational diabetes mellitus. Ginekol Pol. https://doi.org/10.5603/GP.a2021.0083CrossRefPubMed

22.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419. https://doi.org/10.1007/BF00280883CrossRefPubMed

23.

Sitticharoon C, Nway NC, Chatree S, Churintaraphan M, Boonpuan P, Maikaew P (2014) Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors. Peptides 62:164–175. https://doi.org/10.1016/j.peptides.2014.10.006CrossRefPubMed

24.

Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, Crescenti A, Broch M, Aguilar C, Olona M, Porras JA, Hernandez M, Sabench F, del Castillo D, Richart C (2011) New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet 12:60. https://doi.org/10.1186/1471-2350-12-60CrossRefPubMedPubMedCentral

25.

Tan BK, Adya R, Farhatullah S, Lewandowski KC, O’Hare P, Lehnert H, Randeva HS (2008) Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 57:801–808. https://doi.org/10.2337/db07-0990CrossRefPubMed

26.

Wang J, Gao Y, Lin F, Han K, Wang X (2020) Omentin-1 attenuates lipopolysaccharide (LPS)-induced U937 macrophages activation by inhibiting the TLR4/MyD88/NF-κB signaling. Arch Biochem Biophys 679:108187. https://doi.org/10.1016/j.abb.2019.108187CrossRefPubMed

27.

Zhou H, Zhang Z, Qian G, Zhou J (2020) Omentin-1 attenuates adipose tissue inflammation via restoration of TXNIP/NLRP3 signaling in high-fat diet-induced obese mice. Fundam Clin Pharmacol 34:721–735. https://doi.org/10.1111/fcp.12575CrossRefPubMed

28.

Lappas M, Mitton A, Permezel M (2010) In response to oxidative stress, the expression of inflammatory cytokines and antioxidant enzymes are impaired in placenta, but not adipose tissue, of women with gestational diabetes. J Endocrinol 204:75–84. https://doi.org/10.1677/JOE-09-0321CrossRefPubMed

29.

Rojas RR, Lifshitz LM, Bellve KD, Min SY, Pires J, Leung K, Boeras C, Sert A, Draper JT, Corvera S, Moore ST (2015) Human adipose tissue expansion in pregnancy is impaired in gestational diabetes mellitus. Diabetologia 58:2106–2114. https://doi.org/10.1007/s00125-015-3662-0CrossRef

30.

Kuzmicki M, Telejko B, Zonenberg A, Szamatowicz J, Kretowski A, Nikolajuk A, Laudanski P, Gorska M (2008) Circulating pro- and anti-inflammatory cytokines in Polish women with gestational diabetes. Horm Metab Res 40:556–560. https://doi.org/10.1055/s-2008-1073166CrossRefPubMed

31.

Kanigur Sultuybek G, Soydas T, Yenmis G (2019) NF-κB as the mediator of metformin’s effect on ageing and ageing-related diseases. Clin Exp Pharmacol Physiol 46:413–422. https://doi.org/10.1111/1440-1681.13073CrossRefPubMed

32.

He L, He M, Lv X, Pu D, Su P, Liu Z (2010) NF-κB binding activity and pro-inflammatory cytokines expression correlate with body mass index but not glycosylated hemoglobin in Chinese population. Diabetes Res Clin Pract 90:73–80. https://doi.org/10.1016/j.diabres.2010.06.016CrossRefPubMed

33.

Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I (2008) High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57:3090–3098. https://doi.org/10.2337/db08-0564CrossRefPubMedPubMedCentral

34.

Feng H, Su R, Song Y, Wang C, Lin L, Ma J, Yang H (2016) Positive correlation between enhanced expression of TLR4/MyD88/NF-κB with insulin resistance in placentae of gestational diabetes mellitus. PLoS One 11:e0157185. https://doi.org/10.1371/journal.pone.0157185CrossRefPubMedPubMedCentral

35.

Kuzmicki M, Telejko B, Wawrusiewicz-Kurylonek N, Lipinska D, Pliszka J, Wilk J, Zielinska A, Skibicka J, Szamatowicz J, Kretowski A, Gorska M (2013) The expression of genes involved in NF-κB activation in peripheral blood mononuclear cells of patients with gestational diabetes. Eur J Endocrinol 168:419–427. https://doi.org/10.1530/EJE-12-0654CrossRefPubMed

36.

Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fernandez-Real JM, Dandona P (2009) Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal implications for insulin resistance. Diabetes Care 32:2281–2287. https://doi.org/10.2337/dc09-0979CrossRefPubMedPubMedCentral

Titel: Omentin-1 and its relationship with inflammatory factors in maternal plasma and visceral adipose tissue of women with gestational diabetes mellitus
verfasst von: M. I. Peña-Cano
J. Valencia-Ortega
E. Morales-Ávila
M. F. Díaz-Velázquez
R. Gómez-Díaz
R. Saucedo
Publikationsdatum: 01.02.2022
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 2/2022
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-021-01671-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Omentin-1 and its relationship with inflammatory factors in maternal plasma and visceral adipose tissue of women with gestational diabetes mellitus